CytoDyn Balance Sheet - Quarterly (OTCMKTS:CYDY)

Add to My Stocks
$0.63 $0.01 (1.56%) CYDY stock closing price Sep 18, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at CytoDyn balance sheet. All three financial statements should be used to measure the financial performance of the company, and should form a part of the CytoDyn stock analysis. A company releases its balance sheet every quarter along with its quarterly results. CytoDyn had a long term debt of $- at the end of 2018 Q4. To understand the debt servicing capacity of the company, one needs to look at CytoDyn operating cash flow and CytoDyn revenue also. CytoDyn debt to equity ratio is .

View and download CytoDyn quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jun - May2018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Marketable Securities----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets2.09M1.67M3.43M3.33M4.34M4.93M4.75M2.64M1.85M2.01M
Total Current Assets
Property Plant & Equipment----------
Accumulated Depreciation----------
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable-1.05M-1.63M------
Accounts Payable15.84M11.65M9.71M5.67M4.28M5.23M5.9M2.91M2.46M2.38M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses--1.62M-----1.11M-
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities1.32M3.28M2.54M3.37M3.01M3.98M3.95M---
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus159.76M155.71M132.6M126.1M121.73M121.42M113.28M108.7M107.3M101.81M
Retained Earnings-173.14M-163.51M-145.56M-134.61M-122.98M-116.16M-108.04M-102.58M-97.22M-90.72M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity-13.16M-7.59M-12.79M-8.35M-1.1M5.41M5.37M6.25M10.2M11.2M
Total Liabilities & Shareholders Equity4.9M8.28M6.49M6.12M8.05M14.75M15.67M9.29M13.78M14.58M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Apart from balance sheet items, an investor would do well to keep track of the CytoDyn stock price by looking at CytoDyn historical stock prices. One can compare PE with industry average by looking at the CytoDyn PE ratio chart. The common balance sheet items are:

  • Assets: An asset is a resource that a corporation like CytoDyn owns and has monetary significance. CYDY assets decreased from $8.28M in 2018 Q3 to $4.9M in 2018 Q4. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for CytoDyn is $18.06M. Shareholders equity comes under liabilities as it is money the company owes the holders of CYDY stock.

CytoDyn Balance Sheet - Key Ratios